Riskpilot← Back to searchSign inGet full accessSnabelhuset hälsa AB
ABActiveOrg 5592458573Svartbyvägen 1Rental and operating of own or leased real estate · NACE 6820Est. 20201 employees
Revenue 2024
SEK 901K
+4% vs 2023
EBITDA margin
5.1%
+119% vs 2023
Equity ratio
35.0%
Financial strength
Net profit 2024
SEK -6K
+79% vs 2023
| Revenue | SEK 901K | +4% |
| EBITDA | SEK 46K | +119% |
| Net profit | SEK -6K | +79% |
| Total assets | SEK 369K | +9% |
| Equity | SEK 129K | -4% |
| Employees | 1 | — |
Legal name
Snabelhuset hälsa AB
Org number
5592458573
Legal form
Aktiebolag
NACE code
6820 · Rental and operating of own or leased real estate
Founded
3 mars 2020
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolagets verksamhet är fysioterapi, hälsoverksamhet, utbildning inom fysioterapi (föreläsningar och gruppverksamhet). Uthyrning av konferenslokaler. Försäljning av hjälpmedel inom fysioterapi, samt därmed förenlig verksamhet
Address
Svartbyvägen 1
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 310 | 864 | 858 | 865 | 901 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −201 | 104 | 82 | 21 | 46 |
| Depreciation & amort. | −12 | −23 | −27 | −47 | −53 |
| EBIT | −213 | 81 | 55 | −26 | −7 |
| Net financials | — | −6 | — | −1 | 1 |
| Profit before tax | −213 | 75 | 55 | −28 | −6 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −213 | 75 | 55 | −28 | −6 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 219 | 319 | 394 | 339 | 369 |
| Equity | 32 | 107 | 163 | 135 | 129 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 187 | 212 | 231 | 204 | 240 |
| Total debt | 187 | 212 | 231 | 204 | 240 |
EBITDA margin
5.1%
This company
15.8%
Market median
-68% vs market
20202024
Equity ratio
35.0%
This company
38.2%
Market median
+8% vs market
20202024
Return on equity
-4.7%
This company
18.4%
Market median
-126% vs market
20202024
Net profit margin
-0.7%
This company
8.1%
Market median
-109% vs market
20202024
Asset turnover
2.44×
This company
1.12×
Market median
+118% vs market
20202024
Debt / equity
1.86×
This company
0.62×
Market median
-200% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-03-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CI Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2021 | |
| Board of Directors | 2021 | |
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Deputy Board Member | 2020 – 2020 | |
| Board of Directors | 2020 – 2020 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Snabelhuset hälsa AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Cecilia Ida Anette Enbom | Chief Executive Officer | 0 companies |
| Olov Andreas Forslund | Deputy Board Member | 0 companies |
| Linda Gabriella Andersson | Chairman | 0 companies |
| Lennart Patrik Tobias Andersson | Board of Directors | 0 companies |
| A Linnea E Andrén Westermark | Board of Directors | 0 companies |
| Siv Anette Enbom | Deputy Board Member | 0 companies |